The InnoBM (InnoBM Pharmaceuticals Co., Ltd.) was founded in May, 2019. The founder of InnoBM is Dr. Zhuang Liu, who is a world-renown scientist in the field of biomaterials. With our highly experienced team, we are able to swiftly translate cutting-edge technologies from bench to bedside, bringing in revolutionary medicines and solutions to address unmet clinical demands.

Based on the original research from Dr. Liu’s research team, the main focus of InnoBM is currently developing novel therapeutics to boost the efficacy of tumor immunotherapy or interventional therapy. Our aimed products could be used alone, or synergize with existing therapeutics currently used in clinic, to achieve the optimal therapeutic outcome.